NASDAQ · Medical - Healthcare Information Services

Certara, Inc. (CERT) Stock

$10.33 +2.38% NASDAQ: CERT Healthcare

Valuation

MetricValue
Price$10.33
Market Cap$1.58B
P/E Ratio-21.11
P/B Ratio1.49
P/S Ratio3.56
EPS (TTM)$0.00
52-Week High$13.69
52-Week Low$4.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-6.66%
ROA-4.89%
ROCE0.59%
Gross Margin5.01%
Operating Margin5.01%
Net Margin-16.75%
Debt/Equity0.30
Current Ratio2.06

Annual Financials (USD)

Metric20212022202320242025
Revenue$286.0M$336.0M$354.0M$385.0M$419.0M
Operating Profit$14.0M$33.0M$-41.0M$-2.0M$21.0M
Net Profit$-13.0M$15.0M$-55.0M$-12.0M$-2.0M
EPS$-0.09$0.09$-0.35$-0.08$-0.01
Op Margin4.8%9.7%-11.5%-0.5%5.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.5B$1.6B$1.6B$1.6B$1.6B
Total Liabilities$470.0M$493.0M$516.0M$516.0M$494.0M
Cash$186.0M$237.0M$235.0M$179.0M$189.0M
Borrowings$308.0M$308.0M$303.0M$312.0M$11.0M

Latest News

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026 GlobeNewswire · Jul 15, 2026 CERT: Lowering target price to $5.00 Argus Research · Jul 15, 2026 Bank of America Securities Reiterates Buy Rating on Nvidia (NVDA) Insider Monkey · Jul 10, 2026 NVIDIA (NVDA): The Best NASDAQ 100 Stock to Buy Other Than SpaceX Insider Monkey · Jul 9, 2026 AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development Simply Wall St. · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$60.0M$93.0M$83.0M$80.0M$96.0M
Investing Cash Flow$-279.0M$-40.0M$-95.0M$-133.0M$-53.0M
Financing Cash Flow$-6.0M$-4.0M$-6.0M$-25.0M$-61.0M
Net Cash Flow$-87.0M$53.0M$-5.0M$-56.0M$10.0M
Free Cash Flow$51.0M$80.0M$67.0M$59.0M$70.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA18.78
FCF Yield4.23%
Quick Ratio2.55
Interest Coverage0.19
Return 1Y-34.17%
Return 3Y-62.00%
Return 5Y-72.73%

Ownership

Insiders Held2.57%
Institutions Held109.96%
Institutions Float Held112.86%
Institutional HolderSharesReport Date
Blackrock Inc.14,307,8782026-03-31
Dimensional Fund Advisors LP8,562,5082026-03-31
Deerfield Management Company, L.P7,808,6052026-03-31
Jefferies Financial Group Inc.6,858,2092026-03-31
Vanguard Portfolio Management LLC5,969,1962026-03-31

About Certara, Inc.

Certara, Inc. is led by CEO Jon Resnick, employs 1,487 people, headquartered in US, publicly traded since 2020.

Certara, Inc. (CERT) stock trades at $10.33 with a market capitalization of $1.58B. The stock is valued at a negative price-to-earnings (P/E) ratio of -21.11, reflecting a net loss over the last twelve months, price-to-book of 1.49, price-to-sales of 3.56. Over the past 52 weeks the stock has ranged between $4.45 and $13.69, and currently trades 24.5% below its 52-week high.

On profitability, Certara, Inc. generates a return on equity (ROE) of -6.66% (negative, reflecting a net loss), return on capital employed of 0.59%, an operating margin of 5.01%, a net profit margin of -16.75%.

Certara, Inc. by the numbers, 2018–2025

Between 2018 and 2025 Certara, Inc. reported revenue of $164.0M rising to $419.0M, a change of +155.5% across 8 years. Compounded, revenue has grown 11.4% a year over five years, 7.6% over three, 8.8% over the last twelve months. Net profit rose to $-2.0M.

Operating margin went from -2.8% in 2018 to 5.0% in 2025, a gain of 7.9 percentage points. The most recent net margin is -16.75%. On a trailing twelve-month basis to Jun '26, revenue is $409.0M and net profit $-68.0M.

Borrowings fell from $408.0M to $11.0M, cash from operations was $96.0M in the latest year, positive in 8 of the last 8.

Return on equity has averaged -1.3% over five years, and was -0.2% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Certara, Inc. (CERT) — frequently asked questions

What is Certara, Inc. (CERT) stock price today?

Certara, Inc. (CERT) is currently trading at $10.33, up 2.38% today.

What is CERT P/E ratio?

Certara, Inc.'s P/E ratio is -21.11. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is CERT return on equity (ROE)?

Certara, Inc.'s return on equity (ROE) is -6.66%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Certara, Inc.'s market cap?

Certara, Inc. has a market capitalization of $1.58B.

Does CERT pay a dividend?

Certara, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does CERT carry?

Certara, Inc. has a debt-to-equity ratio of 0.30. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is CERT's profit margin?

Certara, Inc. reports a net profit margin of -16.75% — the share of revenue left after every cost, including tax and interest.

What sector is CERT in?

Certara, Inc. is classified under Healthcare, in the Medical - Healthcare Information Services industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is CERT listed on?

Certara, Inc. trades on NASDAQ under the ticker CERT.

What is CERT's 52-week range?

Over the last year Certara, Inc. has traded between $4.45 and $13.69.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens CERT currently matches

On the figures above, Certara, Inc. passes the filters for 5 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksStocks Under $100Stocks Under $50Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.